Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Strong
Garp
Very Strong
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Very Strong
Earnings
Very Strong
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Strong
Website
Indivior Pharmaceuticals, Inc.
Telephone
1.804.379.1040
Address
Suite 125, 10710 Midlothian Turnpike, North Chesterfield, VA 23235
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 11.08 - 41
Trade Value (12mth)
US$16,931,478.00
1 week
0.63%
1 month
14.77%
YTD
3.53%
1 year
227.64%
All time high
41.00
EPS 3 yr Growth
-540.60%
EBITDA Margin
30.50%
Operating Cashflow
-$27m
Free Cash Flow Return
-25.40%
ROIC
197.20%
Interest Coverage
8.40
Quick Ratio
0.50
Shares Outstanding (Fully Diluted)
129m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 16 May 26 | |
| 16 May 26 | |
| 04 May 26 | |
| 01 May 26 | |
| 01 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.94 | 0.05 | 1.68 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.94 | 0.05 | 1.64 | | | | ||
Growth | % | | | | | -146.9 | 105.6 | 3,069.8 | | | | ||
PE | X | | | | | 1,045.9 | 236.3 | 21.9 | | | | ||
EV/EBITDA | X | | | | | 7.7 | 5.6 | 12.5 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
